search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Company insight


principles for established obesity therapy and implements these digitally. Using the data entered, it gives patients personalised recommendations to encourage a healthier lifestyle. The session will be moderated by Lina Behrens, MD of digital drugs company Flying Health.


Digital drugs are used to trigger a direct physiological reaction using software-generated medical stimuli alone. Flying Health spin-offs Dopavision and Neuraltrain develop digital drugs such as these for short-sightedness and mental health, thus aiming to shape the next generation of healthcare. Flying Health also works on advancing and implementing future-oriented IT strategies in the three clinics of the Sister Euthymia Foundation. As well as moderating the session on influencing user behaviour, Behrens will take part in a discussion about health tech and climate change on November 17.


Machine detection of emotions On Tuesday 16 November, the topic on the table at the IT Forum will be emotions and how to detect them using machines. The spotlight will be given to ‘affective computing” – systems and devices that can detect, interpret, process and simulate human feelings. One of the panellists is the head of the Cognitive Assistance Systems Working Group Dr Patrick Gebhard, who leads the EmmA project. The project’s focus is developing a mobile assistance system that can be used for hazard assessments for mental stress in the workplace and when people return to work following a period of mental illness.


Compamed will showcase an extensive range of medical technology products and services on the market, such as individual components, materials and packaging, and high-tech solutions.


join the panel alongside Gottfried Wilhelm Leibniz prize winner Professor Elisabeth André. André established pain recognition as a relevant capability for machine learning-based healthcare assistance. Today, her work is generally used to endow robots or virtual characters with the capability to recognise and react to a human being’s emotions. The final panellist will be Kenza Ait Si Abbou, senior manager of robotics and artificial intelligence at Deutsche Telekom, and the speakers will be moderated by Dr Nana Bit-Avragim, mentor and advisor at EIT Health.


Laboratory medicine Innovative molecular biological methods, Covid-19, the latest developments at universities and in the industry – these


“There are three keywords that sum up this year’s Labmed Forum. The first is genomics... Secondly, we will be focusing on aspects and vaccinations related to Covid-19, and thirdly we will be taking a closer look at research and innovative projects.”


The starting point is a multimodal real-time sensor analysis with the aid of smartphones, which enables the interpretation of physiological and social signals. The Bavarian company audEERING is going one step further and is looking to detect whether users have Covid-19 using audio recordings. Dagmar Schuller, co-founder of audEERING, will


Practical Patient Care / www.practical-patient-care.com


core themes determine the four-day programme dedicated to the diagnostic field of laboratory medicine. The latest scientific findings in the fields of virology, infectiology, immunology, microbiology and biotechnology will be presented as part of the Medica Labmed Forum. It will offer medical professionals, healthcare providers and industry representatives a range of


highly topical talks by specialists from around the globe in Hall 1. On day one, top-class speakers will hold short presentations and take part in interactive panel discussions that revolve around microbiology and metagenomics – with a particular focus on Covid-19. On the second day, cardiology and oncology take centre stage, while the third and fourth days of the event take a closer look at the latest developments in the university field and industry. “On the whole, there are three keywords that sum up this year’s Labmed Forum,” said Professor Dr Georg Hoffmann of Trillium, specialists for medical publications, which organised the event series in cooperation with the German Heart Centre in Munich. “The first is genomics, in other words, the latest molecular biological methods that look at a genome in its entirety. Secondly, we will be focussing on aspects and vaccinations related to Covid- 19, and thirdly we will be taking a closer look at research and innovative projects at universities and in the industry.” The trade fair halls are open from 10am until 6pm every day. All visitors and exhibitors must comply with Germany’s 3G rule for Covid-19 safety (they must be vaccinated, recovered or tested) in order to enter the premises. Tickets can be purchased online. All information, including current news on the hygiene and infection protection concept at Medica 2021 and Compamed 2021,can be viewed online. ●


www.medica-tradefair.com www.compamed-tradefair.com


11


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57